NGENLA

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: 280a85857052fdf2
Drug Approval Canada Name: NGENLA
Product Name: NGENLA
Status: Marketed
Status Date: 2022-02-22
Original Market Date: 2022-02-22
Din: 02521679
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D , Prescription
Ahfs: 68:28.00
Atc Original: H01AC08 SOMATROGON
Atc Name: h 01 ac 08
Aig Number: 0163234001
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

SOMATROGON

20 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

280a85857052fdf2

Type

Standard